JPM: 100 biopharma execs take gender-diversity pledge
More than 100 biopharma leaders have signed an open letter advocating for the adoption of 10 best practices to increase gender diversity in the industry.
MassBio drafted lists of guiding principles and best practices and got biopharma executives to commit to them. The result is a letter that commits executives from companies including AbbVie, Sanofi and LifeSci Advisors to taking steps to improve the gender diversity of their organizations and address unconscious biases.
Some of the commitments are important but intangible, such as declarations that gender diversity is a priority. But others tie the signatories to making concrete changes to how they run their businesses.
